|
US2005014161A1
|
|
Ribonucleases and methods of making them recombinantly
|
|
US2004126865A1
|
|
Nucleic acids encoding ranpirnase variants and methods of making them
|
|
US6175003B1
|
|
Nucleic acids encoding ribonucleases and methods of making them
|
|
US6239257B1
|
|
Family of proteins belonging to the pancreatic ribonuclease a superfamily
|
|
US6290951B1
|
|
Alteration of the cell cycle in vivo, and particularly for inducing apoptosis of tumor cells
|
|
US5728805A
|
|
Pharmaceuticals and method for making them
|
|
US5559212A
|
|
Frog embryo and egg-derived tumor cell anti-proliferation protein
|
|
US5529775A
|
|
Compositions comprising ONCONASE(™) and cisplatin, melphalan, or doxorubicin HCl
|
|
US5540925A
|
|
Compositions comprising ONCONASE (TM) and STELAZINE (TM) or TAMOXIFEN (TM)
|
|
WO9403197A1
|
|
Pharmaceuticals containing onconase and cisplatin, melphalan and adriamycin
|
|
US5595734A
|
|
Compositions comprising ONCONASE (tm) and lovastatin
|
|
EP0500589A1
|
|
Purified protein and bioactive pharmaceutical
|
|
US4882421A
|
|
Pharmaceutical for treating tumors and method for making it
|
|
IL79571D0
|
|
Pharmaceutical composition for treating tumors in humans and methods for making and using it
|
